Aveshka announces Dr. Til Jolly as Chief Medical Officer

WASHINGTON, Aug. 10, 2020 /PRNewswire/ — Aveshka announced Dr. Til Jolly will join the company’s executive team as the Chief Medical Officer (CMO). 

Dr. Jolly is a board-certified emergency physician with a wide range of experience in the government and private sector. He served as a part-time consultant to Aveshka since 2019 as the Senior Emergency Care Consultant to the Assistant Secretary for Preparedness and Response at the Department of Health and Human Services and will continue to support these areas.

Previously, Dr. Jolly served in myriad capacities to include CMO of SOC Telemed, Deputy CMO and Associate CMO with the Department of Homeland Security (DHS) Office of Health Affairs (OHA), and Senior Science Advisor for the National Exercise Division of the Federal Emergency Management Agency (FEMA). He also worked with the National Football League for 11 Super Bowls, advising on stadium security matters. In these roles, he coordinated across multiple areas of expertise including preparedness, digital health and technology, clinical medicine, public health, and risk communications.

As CMO, Dr. Jolly will directly support clients by providing clinical leadership and direction for all public health and healthcare matters. He will be responsible for all clinical content of Aveshka’s educational programs and contribute to overall product and services priorities, polices, and initiatives that improve preparedness and response within Aveshka’s clients’ environments.

“Dr. Jolly will no doubt be a crucial component of Aveshka’s important work in public health and emergency management,” said Girish Jindia, Aveshka President and CEO. “His vision for Aveshka’s services and ‘all-hazards’ approach is greatly aligned with our goal of continuous improvement and expansion of our capabilities for both current and future customers, while rendering Aveshka as a go-to thought leader in these realms.”

“I look forward to working with Aveshka’s team and helping its growing customer base accomplish their critical missions,” said Dr. Jolly. “The intersection of health with all threats across critical infrastructure has always been apparent, but in today’s environment is at the top of every leader’s priority list. Digital health and other innovations provide opportunities to approach health threats in new and exciting ways.”

ABOUT AVESHKA, INC.
Aveshka is a thought leader that integrates strategy, technology and innovation to deliver cutting edge, breakthrough solutions that strengthen the nation against security threats. Aveshka accelerates the advantage for its customers’ missions, rendering them protected today and prepared for a safer and smarter tomorrow. Visit www.aveshka.com.

View original content to download multimedia:http://www.prnewswire.com/news-releases/aveshka-announces-dr-til-jolly-as-chief-medical-officer-301109093.html

SOURCE Aveshka, Inc.

Staff

Recent Posts

cbdMD Announces Company’s CEO Joins the Board of Directors

Charlotte, North Carolina--(Newsfile Corp. - December 23, 2024) - cbdMD, Inc. (NYSE American: YCBD) (NYSE…

3 hours ago

Interactive Strength Inc. (Nasdaq: TRNR) Issues Year-End Update, Looks Ahead to 2025

AUSTIN, TEXAS / ACCESSWIRE / December 23, 2024 / Interactive Strength Inc. (Nasdaq:TRNR) ("TRNR" or…

4 hours ago

Quest Diagnostics Upholds Strong Governance and Ethics With Robust Oversight, ESG Integration, and Comprehensive Risk Management

Originally published in Quest Diagnostics' 2023 Corporate Responsibility ReportNORTHAMPTON, MA / ACCESSWIRE / December 23,…

4 hours ago

Phio Pharmaceuticals Announces Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Marlborough, Massachusetts--(Newsfile Corp. - December 23, 2024) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO), a clinical-stage…

5 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

6 hours ago

ILiAD Biotechnologies Announces the Passing of Chief Operating Officer Ken Solovay

WESTON, Fla.--(BUSINESS WIRE)--ILiAD Biotechnologies, LLC (ILiAD), a clinical stage biotech company developing the world’s most…

7 hours ago